We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr, Par Settle With Valeant Over Epilepsy Drug

Law360 (October 15, 2007, 12:00 AM EDT) -- Barr Pharmaceuticals Inc. and Par Pharmaceutical Cos. Inc. have finalized a settlement with Valeant Pharmaceuticals North America over a generic version of Valeant’s epileptic seizure treatments Diastat and Diastat AcuDial....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.